MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,246,000 | +74.9% | 350,000 | +45.1% | 4.62% | +71.5% |
| Q2 2023 | $8,715,026 | +136.7% | 241,213 | +357.5% | 2.70% | +116.3% |
| Q3 2022 | $3,682,000 | -60.1% | 52,720 | -61.6% | 1.25% | -56.1% |
| Q2 2022 | $9,217,000 | +143.1% | 137,303 | +197.7% | 2.84% | +80.8% |
| Q1 2022 | $3,792,000 | -57.5% | 46,122 | -24.1% | 1.57% | -56.6% |
| Q4 2021 | $8,912,000 | +9.7% | 60,757 | +32.3% | 3.61% | -21.4% |
| Q3 2021 | $8,127,000 | +33.3% | 45,941 | +21.7% | 4.60% | +68.9% |
| Q2 2021 | $6,098,000 | +611.6% | 37,753 | +655.1% | 2.72% | +482.4% |
| Q1 2021 | $857,000 | -80.5% | 5,000 | -75.0% | 0.47% | -81.7% |
| Q4 2020 | $4,393,000 | – | 20,000 | – | 2.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |